经皮膀胱肿瘤活检的安全性与诊断取材率
回顾性分析2009年2月1日至2025年2月1日共58例患者59次经皮膀胱肿瘤活检,全部技术成功,CT引导占88.1%、17/18G同轴核心活检系统占84.7%,活检结果诊断性94.9%,与手术病理一致13/14(92.9%),无严重不良事件或操作相关死亡,作者认为经皮活检是膀胱肿瘤取材的安全有效方法。
要点
- 经皮膀胱肿瘤活检技术成功率高,本组59次操作全部技术成功。
- 本组活检结果诊断性达94.9%,与后续手术病理一致13/14(92.9%)。
- 本组无严重不良事件或操作相关死亡,仅见2例轻度尿路感染和2例需治疗的中度出血。
核心结论
- 作者结论认为经皮活检是膀胱肿瘤取材的安全有效方法。
研究设计与样本
- 回顾性机构数据库 review,纳入2009年2月1日至2025年2月1日间58例患者共59次膀胱肿瘤活检。
- 记录患者、操作及病理特征,不良事件按介入放射学会(Society of Interventional Radiology)标准分类。
关键影像表现/征象
- 全部操作技术成功,多数采用CT引导(88.1%)及17/18G同轴核心活检系统(84.7%)。
诊断标准与关键数值
- 活检结果诊断性为94.9%。
- 在随后接受经尿道切除或膀胱切除的14例中,活检与手术病理一致13例(92.9%)。
临床应用与阅片要点
- 本组无严重不良事件或操作相关死亡,出现2例活检后轻度尿路感染和2例需治疗的中度出血。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Conventional bladder tumor diagnosis consists of transurethral resections, which are not always feasible and can entail significant morbidity for vulnerable patients. This study was conducted to evaluate the safety and diagnostic yield percutaneous urinary bladder tumor biopsy as an alternative for such cases.
METHODS: Retrospective review of an institutional database identified 58 patients who underwent 59 bladder tumor biopsies between February 1, 2009 and February 1, 2025. Patient, procedural, and pathologic characteristics were recorded. Adverse events were classified according to Society of Interventional Radiology criteria.
RESULTS: Mean patient age was 68 years (range: 22-90). All procedures were technically successful. Most cases used CT guidance (88.1%) and 17/18 gauge coaxial core biopsy systems (84.7%). Biopsy results were diagnostic in 94.9% of cases. Biopsy results were concordant with surgical pathology in 13/14 (92.9%) patients who subsequently underwent transurethral resection or cystectomy. There were no severe adverse events or procedure-related mortality. There were two minor urinary tract infections following biopsy and two moderate bleeding events requiring treatment.
CONCLUSION: Percutaneous biopsy is a safe and effective method for sampling urinary bladder tumors.
引用
- Tucker J, Sharma V, Johnson M, et al. Safety and Diagnostic Yield of Percutaneous Urinary Bladder Tumor Biopsy. Abdom Radiol (NY). 2025. PMID: 40719926. doi:10.1007/s00261-025-05139-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。